1. Aberrant DNA Methylation in Chronic Myeloid Leukemia: Cell Fate Control, Prognosis, and Therapeutic Response
   Masumeh Maleki Behzad et al, 2018, Biochemical Genetics CrossRef
2. Diagnostic potential of exosomal extracellular vesicles in oncology
   Mickensone Andre et al, 2024, BMC Cancer CrossRef
3. Chemotherapy-induced hypomethylation of N-myc downstream-regulated gene 4 in the bone marrow of patients with acute myeloid leukemia
   Qingxiao Hong et al, 2017, Oncology Letters CrossRef
4. DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome
   Geórgia Muccillo Dexheimer et al, 2017, Disease Markers CrossRef
5. Aberrant HIF1- α and SIX-1 Expression is Associated with Poor Prognosis in Acute Myeloid Leukemia Patients with Isocitrate Dehydrogenase 1 Mutations
   Tariq Ali et al, 2024, Cancer Control CrossRef
6. Gout in males: a possible role for COMT hypomethylation
   Xiuru Ying et al, 2019, Clinical Rheumatology CrossRef
7. CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population
   Bin Li et al, 2017, Immunology Letters CrossRef
8. CBS promoter hypermethylation increases the risk of hypertension and stroke
   Changyi Wang et al, 2019, Clinics CrossRef
9. DNA Methylation Clusters and Their Relation to Cytogenetic Features in Pediatric AML
   Jatinder K. Lamba et al, 2020, Cancers CrossRef
10. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
    Grégoire Cullot et al, 2019, Nature Communications CrossRef
11. Association of BAX hypermethylation with coronary heart disease is specific to individuals aged over 70
    Limei Zhang et al, 2019, Medicine CrossRef
12. Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells
    Zachary D. Nagel et al, 2019, PLOS ONE CrossRef